More Articles

older male patient and doctor
October 14, 2022 | Acute Coronary Syndromes

Polypills—single pills that contain a low-cost blood pressure medication, a statin and aspirin—could potentially save millions of lives each year. So why are they not being prescribed more throughout the world? Two leading…

Using fractional flow reserve (FFR) measurements to guide percutaneous coronary intervention (PCI) procedures for patients presenting with multivessel coronary artery disease (CAD) is associated fewer stent implantations, according to a new meta-analysis published in the American Journal of Cardiology. The study’s authors also emphasized that FFR-guided PCI can help improve resource utilization by identifying lesions that do not require treatment.
October 11, 2022 | Interventional Cardiology

Using fractional flow reserve (FFR) measurements to guide percutaneous coronary intervention (PCI) procedures for patients presenting with multivessel coronary artery disease (CAD) is associated with fewer stent implantations,…

Microbot Medical microcatheters Liberty Robotic System
October 10, 2022 | Vascular & Endovascular

Microbot Medical, a Massachusetts-based medical device company focused using microrobotic technology to perform endovascular procedures, announced that it has acquired Nitiloop’s assets, including the NovaCross family of…

Interventional cardiologists performing PCI
October 05, 2022 | Interventional Cardiology

Long-term P2Y12 inhibitor monotherapy after an initial three months of dual antiplatelet therapy (DAPT) is associated with three-year percutaneous coronary intervention (PCI) outcomes similar to prolonged DAPT, according to new…

Electrocardiograms analyzed by AI can offer information about mortality risk.
October 03, 2022 | Heart Rhythm

Using artificial intelligence (AI) to screen patients for atrial fibrillation (AFib) can detect new cases that may have otherwise been missed, according…

A TAVR procedure being performed at Northwestern Medicine in Chicago.
September 29, 2022 | TAVR

Timely interventions and communication between cardiologists and neurologists can improve outcomes for transcatheter aortic valve replacement (…

The Pulnovo pulmonary artery denervation catheter. In February 2021, the devices was granted the U.S. Food and Drug Administration (FDA) breakthrough device designation. #TCT2022 #PAH
September 21, 2022 | Interventional Cardiology

A late-breaking sham-controlled clinical evaluation of pulmonary artery denervation (PADN) for patients with pulmonary arterial hypertension (PAH) found that in addition to increasing exercise capacity, PADN improved hemodynamics and clinical…

Use of ultrasound to guide needles used for femoral vascular access for cath lab procedures can help reduce bleeding and vascular complications. But the Universal Trial at TCT 2022 showed no difference. Image courtesy of Sonosite
September 20, 2022 | Interventional Imaging

In one of the largest multicenter randomized trials comparing ultrasound with fluoroscopic guidance vs. fluoroscopic guidance alone to guide femoral artery vascular access for patients undergoing cardiac procedures, many were surprised to find…

birth control the pill cardiovascular disease blood clots side effects
September 15, 2022 | Heart Health

Obese women who take certain oral contraceptives face a heightened risk of venous thromboembolism (VTE), according to new research out of Italy. The risk of developing a potentially fatal blood clot is especially high among women…

Coronary CT Angiography (CCTA) has evolved into a much more helpful resource than interventional cardiologists may have originally believed. In fact, the Society of Cardiovascular Computed Tomography (SCCT) emphasized in a new expert consensus statement that CCTA provides specialists with an effective tool in the preparation and optimization of coronary procedures. The 2021 chest pain guidelines elevated CTA to a class 1A recommendation. Harold Litt , MD, explains the use of CCTA in the ED.
August 30, 2022 | Interventional Cardiology

Coronary CT Angiography (CCTA) has evolved into a much more helpful resource than interventional cardiologists may have originally believed…

Meds Drugs Pharma
August 29, 2022 | Cardiac Surgery

After coronary artery bypass graft (CABG) surgery, a regimen of ticagrelor plus aspirin significantly reduced patients’ risk of vein graft failure compared to aspirin alone, according to a new meta-analysis…

When kidney cancer invades a patient’s inferior vena cava (IVC), robotic-assisted radical nephrectomy with IVC thrombectomy is a safe and effective alternative to open surgery, according to a new meta-analysis published in the Journal of Urology.[1]
August 22, 2022 | Vascular & Endovascular

When kidney cancer invades a patient’s inferior vena cava (IVC), robotic-assisted radical nephrectomy with IVC thrombectomy is a safe and effective alternative to open surgery, according to a new meta-analysis published in the

A heart attack is caused when one of the coronary arteries becomes blocked with a clot.
August 19, 2022 | Acute Coronary Syndromes

Monitoring patient symptoms is an essential part of diagnosing and treating cardiovascular disease (CVD). A new scientific statement from the American Heart Association (AHA), published in

Interventional cardiologists at the University of Washington (UW) have used the new Ōnocor catheter-delivered retrieval device to remove a benign tumor from a patient’s heart. This is the first time such a device has ever been used to remove a heart tumor.
August 18, 2022 | Interventional Cardiology

Interventional cardiologists at the University of Washington (UW) have used a new catheter-delivered retrieval device to remove a benign tumor from a patient’s heart. This is the first time…

August 15, 2022 | Vascular & Endovascular

Boston Scientific has announced its acquisition of Obsidio, a South Carolina-based medical device company that developed a new…

The Harmony pulmonary valve was among the devices involved with the FDA Breakthrough Device Designation program that gained more rapid market clearance. The FDA graph shows cardiovascular devices leading the types of devices involved in the program.
August 04, 2022 | Vascular & Endovascular

U.S. Food and Drug Administration (FDA) said cardiovascular devices make up the largest number of technologies accepted into the FDA Breakthrough Devices Program. These devices also make up a large percentage of devices that have made it to final…

doctors.jpg
August 02, 2022 | Acute Coronary Syndromes

New data from the U.S. Census Bureau suggest that cardiovascular disease (CVD) rates in the United States will increase significantly in the years ahead. A team of specialists from…

Researchers said they were surprised to learn that "no pain, no gain" was so accurate for patients with peripheral artery disease (PAD). A news study found patients should push past the pain because it improves outcomes.  
July 29, 2022 | Vascular & Endovascular

Patients with peripheral artery disease (PAD) can see considerable benefits if they exercise at a pace that causes discomfort, or even a little pain, in their legs. That takeaway comes from a new analysis published in the Journal…

anticoagulation UNC Charlotte RNA DNA
July 19, 2022 | Pharmaceutics

Researchers have developed a new anticoagulant platform that uses programmable RNA-DNA anticoagulant fibers designed to prevent blood clots without leading to unwanted side effects such as in-hospital bleeding…